Dr. Helen Li specializes in ocular oncology and vitreoretinal diseases. She founded the Community Retina Group in Houston after almost twenty years of clinical practice at the University of Texas Medical Branch, where she received numerous teaching award from residents and fellows. Dr. Li served as director of the UTMB retina service and founded the retina fellowship program. She regularly publishes her research in leading ophthalmology journals and presents on retinal diseases and ocular tumors at national and international scientific conferences.
Board certified by the American Board of Ophthalmology, Dr. Li is an active member of professional organizations, including the Macular Society, Retina Society, the International Society of Ocular Oncology, the American Uveitis Society, the Association of Research in Vision and the Ophthalmology and the American Telemedicine Association.
Dr. Li has served as principle investigator of National Eye Institute, industry and foundation sponsored research and clinical trials. Her research projects include the ocular complications of AIDS trial and the diabetic retinopathy clinical research network study. She is currently interested in validating biomarkers for prognosis of melanoma in the eye and evaluating novel therapeutics for various types of ocular cancer.